Carsyon 2 Te Egyan Nov18

During RCPA (Retail Chemist Prescription Audit), it is necessary to ask about all of the above options. Quantified information of our brand is important to assess its performance in the market and identify areas for improvement. Quantified information of competitor brands helps in understanding the competitive landscape and making strategic decisions. Pack and price of competitor brands provide insights into their marketing strategies and pricing tactics. Therefore, asking about all of the above options is essential for a comprehensive RCPA.

Azilsartan contains the moiety (ring) known as Oxo-Oxadiazole. This is evident from the given options where Oxo-Oxadiazole is the only ring mentioned.

The indication for Turbovas CV is in the secondary prevention of ACS (acute coronary syndrome) and ischemic stroke. This means that Turbovas CV is recommended for patients who have already experienced an ACS event or an ischemic stroke and need medication to prevent future occurrences. It is not indicated for dyslipidemia or mixed dyslipidemia alone.

The competitor brand of Rosuvastatin and Clopidogrel from Ajanta pharma is Rosufit CV.

Azilsartan offers additional vasodilation due to its action on ACE-2/Ang (1-7) and mass receptor. ACE-2 is an enzyme that converts Angiotensin II (Ang II) into Angiotensin (1-7), which has vasodilatory effects. Azilsartan enhances the activity of ACE-2, leading to increased production of Ang (1-7). This, in turn, promotes vasodilation and helps to lower blood pressure. Additionally, Azilsartan may also have an effect on the mass receptor, further contributing to its vasodilatory properties.

If the retailer is busy with a patient, it is polite and respectful to wait on one side until he is free. This shows patience and consideration for the retailer's current engagement and allows him to give his full attention to the patient.

If a brand is lying at a chemist and not moving, it suggests that the brand is not selling well and is not in demand. In order to avoid losses, it would be best to try to liquidate the brand by selling it at a discounted price or through other promotional strategies. Ignoring it would not solve the issue and asking the chemist to return it may not be possible or practical. Therefore, the best option would be to try to liquidate the brand.

Gliclazide belongs to the class of drugs known as sulfonylureas (SU). These drugs are commonly used to treat type 2 diabetes by stimulating the pancreas to produce more insulin. Gliclazide works by increasing the release of insulin from the beta cells in the pancreas, which helps to lower blood sugar levels. Therefore, the correct answer is SU.

Azilsartan is 31% more effective than Olmesartan for blood pressure control. This means that Azilsartan has been shown to provide a greater reduction in blood pressure compared to Olmesartan, leading to better control of hypertension. It is important to note that this percentage represents the relative difference in effectiveness between the two medications, indicating that Azilsartan is the more favorable option for managing blood pressure.

The full form of RCPA is Retail Chemist Prescription Audit.

According to Hurst's The Heart textbook, one of the most effective 2 drug combinations to treat Hypertension is ARB (Angiotensin Receptor Blockers) and Diuretics. This combination helps to lower blood pressure by blocking the effects of angiotensin and removing excess fluid and salt from the body. ARBs relax blood vessels, while diuretics increase urine production, both working together to reduce hypertension.

not-available-via-ai

The given answer, "Lower," suggests that Azilsartan has a lower IC50 value than Olmesartan. This implies that Azilsartan is more potent or effective in inhibiting the target enzyme or receptor compared to Olmesartan. A lower IC50 value indicates a higher affinity or stronger binding of the drug to its target, resulting in a more significant biological effect at lower concentrations.

81% of patients achieved blood pressure control with the combination of Azilsartan and Chlorthalidone. This means that out of all the patients who took this fixed dose combination, 81% of them were able to successfully control their blood pressure. This indicates that the combination of Azilsartan and Chlorthalidone is effective in managing high blood pressure in a significant majority of patients.

The correct answer explains that Turbovas F USP improves lipid profile by reducing high levels of LDL cholesterol, high triglycerides (TG), and low levels of HDL cholesterol. The American Diabetes Association (ADA) recommends considering the combination of Turbovas F in patients with TG levels greater than 204 mg/dl and HDL levels less than 34 mg/dl. This combination helps to prevent future cardiovascular events. Additionally, Turbovas F, being a non CYP3A4 metabolized statin, enhances the efficacy of Clopidogrel, unlike Atorvastatin, which is a CYP3A4 metabolized statin. Therefore, the correct answer includes both the improvement of lipid profile and the prevention of future events.

Chlorthalidone belongs to the class of thiazide-like diuretics. Thiazide-like diuretics have similar mechanisms of action to thiazide diuretics, but they have a longer duration of action. They work by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, leading to increased excretion of sodium and water. This helps to reduce blood volume and lower blood pressure. Chlorthalidone is commonly used to treat hypertension and edema.

RCPA stands for Rapport, Collecting Information, Presenting, and Acknowledging. It is a framework used in sales and customer service to establish a connection with the customer and gather necessary information. Therefore, the correct answer is "Rapport building" as it is the first step in the RCPA process.

During a retailer call, Pob can ensure both the availability of your brand and that prescriptions will not get bounced. This means that Pob can help make sure that the retailer has your brand in stock and that any prescriptions for your brand will be filled without any issues.

Rosuvastatin acts by inhibiting the enzyme HMGCoA Reductase and preventing the formation of cholesterol.

To determine the potential of a doctor by RCPA, we need to do two things. First, we need to note down the information about the doctor. Second, we need to analyze the information both prescription-wise and value-wise. By doing these two steps, we can assess the potential of the doctor.

The correct answer is "On his suitable Time". This answer suggests that the meeting should be scheduled at a time that is convenient for the retailer. This shows consideration and respect for the retailer's schedule and availability, which can help foster a positive relationship and cooperation between the two parties.

No, dose adjustment of Azilsartan is not required in renal impairment patients. Azilsartan is primarily eliminated through hepatic metabolism, and only a small fraction is excreted unchanged in the urine. Therefore, renal impairment does not significantly affect the pharmacokinetics of Azilsartan, and no dose adjustment is necessary in these patients.

The correct answer is "Low HDL, High TG, High LDL." This combination of lipid levels is often referred to as the lipid triad and is commonly seen in individuals with metabolic syndrome or insulin resistance. Low HDL (high-density lipoprotein) levels are associated with an increased risk of cardiovascular disease, while high TG (triglyceride) and high LDL (low-density lipoprotein) levels are also risk factors for heart disease. Therefore, Turbovas F, a medication used to treat dyslipidemia, would be needed to address these abnormal lipid levels.

RCPA, which stands for Right Customer for Right Brand, is helpful in several ways. It helps in selecting the right customer for a particular brand, as well as understanding the prescription habits of doctors. Additionally, it aids in planning a strategy for marketing and sales. Therefore, the correct answer is "All of above".

The price of Turbovas is Rs. 27 per tablet.

The US Task Force in 2016 recommended that adults between the ages of 40-75 who do not have a history of cardiovascular disease (CVD) but have at least one cardiovascular (CV) risk factor should be given a low to moderate dose of statin. This recommendation is based on the understanding that statins can help reduce the risk of developing CVD in this population. High dose statins are recommended for high-risk individuals, while combination treatment is suggested for managing lipid triad.

The correct answer is ZILARTA CT. This means that the second prevalence study will specifically focus on ZILARTA CT, which suggests that there may be different studies or investigations being conducted for different variations or forms of ZILARTA. The other options, ZILARTA, ZILARTA & ZILARTA CT both, and None of the above, are not the main focus of the second prevalence study.

The main benefit of HPMC Technology used in Dianorm OD is that it offers a similar release profile of the full and half tablet. This means that the medication is released at a consistent rate, regardless of whether the patient takes a full tablet or cuts it in half. This ensures that the patient receives the intended dosage of the medication, regardless of their preferred method of administration.

The correct answer is "Precall Planning." Precall planning refers to the process of preparing for a sales call or meeting with a potential customer. It involves researching the customer's needs and preferences, setting objectives for the meeting, and developing a strategy to effectively communicate and persuade the customer. RCPA, which stands for "Recall Planning and Analysis," does not exist as a commonly used term or concept in sales or business. Therefore, the correct answer is "Precall Planning."

The correct answer is "Sub optimal dosage of statin." This suggests that most high-risk dyslipidemic Indian patients are not receiving the recommended or optimal dosage of statin medication. This could be due to various reasons such as inadequate prescription by healthcare providers, patient non-compliance, or lack of awareness about the appropriate dosage for this specific population. It is important for healthcare professionals to ensure that patients are prescribed and taking the appropriate dosage of statin to effectively manage their dyslipidemia and reduce the risk of cardiovascular events.